Cellerant Therapeutics, Inc. Appoints Gisela Schwab, M.D., to Its Board of Directors and Names Lowell Sears as Chairman of the Board

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today the appointment of Gisela Schwab, M.D. to its Board of Directors and the appointment of Lowell Sears as Chairman of the Board. Richard Rathmann, Cellerant’s former Chairman of the Board, will remain a director on the Board.